Literature DB >> 8778036

Epidermal Langerhans' cell induction of immunity against an ultraviolet-induced skin tumour.

L L Cavanagh1, R Sluyter, K G Henderson, R S Barnetson, G M Halliday.   

Abstract

Langerhans' cells (LC) have been shown experimentally to induce immune responses against many antigens; however, their role in the initiation of anti-tumour immunity has received little attention. This study examined the ability of murine epidermal LC to induce immunity to an ultraviolet radiation (UV)-induced skin tumour. Freshly prepared epidermal cells (EC) were cultured for 2 or 20 hr with granulocyte-macrophage colony-stimulating factor (GM-CSF), pulsed with an extract of the UV-13-1 tumour, then used to immunize naive syngeneic mice. Delayed type hypersensitivity (DTH) was elicited 10 days after immunization by injection of UV-13-1 tumour cells into the ear pinna, and measured 24 hr later. EC cultured with GM-CSF for 2 hr induced antitumour DTH, as did EC cultured for 20 hr without GM-CSF. Conversely, EC cultured for 2 hr without GM-CSF, or EC cultured for 20 hr with GM-CSF were unable to induce a DTH. Induction of immunity required active presentation of tumour antigens by Ia+ EC and was tumour specific. Thus Ia+ epidermal cells are capable of inducing anti-tumour immunity to UV-induced skin tumours, but only when they contact antigen in particular states of maturation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8778036      PMCID: PMC1384119     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

1.  Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level.

Authors:  G Girolomoni; G Zambruno; R Manfredini; V Zacchi; S Ferrari; A Cossarizza; A Giannetti
Journal:  J Invest Dermatol       Date:  1994-07       Impact factor: 8.551

2.  Quantitation of surface antigens on cultured murine epidermal Langerhans cells: rapid and selective increase in the level of surface MHC products.

Authors:  M D Witmer-Pack; J Valinsky; W Olivier; R M Steinman
Journal:  J Invest Dermatol       Date:  1988-03       Impact factor: 8.551

3.  Antigenicity of murine skin tumors induced by ultraviolet light.

Authors:  M L Kripke
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

4.  Immunologic functions of Ia-bearing epidermal Langerhans cells.

Authors:  G Stingl; S I Katz; L Clement; I Green; E M Shevach
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

Review 5.  Langerhans cells: antigen presenting cells of the epidermis.

Authors:  J W Streilein; P R Bergstresser
Journal:  Immunobiology       Date:  1984-12       Impact factor: 3.144

Review 6.  Immunologic mechanisms in UV radiation carcinogenesis.

Authors:  M L Kripke
Journal:  Adv Cancer Res       Date:  1981       Impact factor: 6.242

7.  Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.

Authors:  J S Peeler; J Y Niederkorn
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

8.  Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells.

Authors:  S Sullivan; P R Bergstresser; R E Tigelaar; J W Streilein
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

9.  The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.

Authors:  H Fujiwara; M Fukuzawa; T Yoshioka; H Nakajima; T Hamaoka
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

10.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.

Authors:  G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.